Abstract

Knowledge about newborn screening (NBS) is an important factor for parents to make an informed decision about participation. In Europe, countries inform parents differently about their NBS program, potentially including different knowledge aspects in their information. The aim of this study was to assess twenty-six European parental information products and to analyze their knowledge aspects through a content analysis. The analyzed aspects were compared to a list of eight knowledge aspects from scientific literature. The list includes aspects important for parents’ decision-making, such as the purpose of screening. The study showed that most of the eight knowledge aspects are included in NBS information products of the majority of countries. However, there were differences between countries, for example in the amount of detail and phrasing of the information. Additional relevant knowledge aspects have also been identified and are recommended to optimize information products, such as the handling of residual bloodspot samples. This study only assessed knowledge aspects in information products meant for printing, but many countries also use other communication methods, and the impact on knowledge of the delivery of the information needs further study. Preferences of parents on alternative communication methods need to be considered and evaluated on their effectiveness.

Highlights

  • In newborn screening (NBS) programs worldwide, babies are screened for rare, congenital disorders through analysis of a blood sample [1]

  • We aim to contribute to insights about common elements in parental information about NBS in Europe and how this information is presented by analyzing European information products for parents, by using the General Medical Council (GMC)’s knowledge aspects

  • In addition to the eight knowledge aspects formulated by the GMC, the open coding showed additional items that we considered as relevant knowledge items

Read more

Summary

Introduction

In newborn screening (NBS) programs worldwide, babies are screened for rare, congenital disorders through analysis of a blood sample [1]. NBS programs have developed from programs that screen for a small number of conditions to complex programs sometimes including over 50 conditions. Countries differ in the programs they have in place. Different interpretations of screening criteria, local politics, healthcare structures, and varying perspectives on how to implement NBS contribute to these program differences [3,4,5,6,7]. Countries differ in the conditions screened, screening methodology, storage of residual specimens, and information provided to parents [6,8]. We will focus on parental information about NBS

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call